The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III study of vinflunine versus an alkylating agent of physician’s choice in metastatic breast cancer (MBC) previously treated with or resistant to an anthracycline, a taxane, an antimetabolite and a vinca-alkaloid.
 
Javier Cortes
Honoraria - Celgene; Eisai; Novartis; Roche Pharma AG
Consulting or Advisory Role - Celgene; Roche Pharma AG
 
Christelle Levy
No Relationships to Disclose
 
Yuri Demidchik
No Relationships to Disclose
 
Laslo Roman
No Relationships to Disclose
 
Hugues Pierre Bourgeois
Travel, Accommodations, Expenses - Novartis
 
Corinne Veyret
No Relationships to Disclose
 
Simon Spazzapan
Honoraria - Celgene
Travel, Accommodations, Expenses - Celgene; Novartis
 
Jean-Marc Ferrero
No Relationships to Disclose
 
Ta-Chung Chao
No Relationships to Disclose
 
Yauheniya Karchmit
No Relationships to Disclose
 
Marc Espie
Consulting or Advisory Role - Pierre Fabre
 
Jean-Marc A. Nabholtz
No Relationships to Disclose
 
Xavier Gonzalez
No Relationships to Disclose
 
Vasili Beliakouski
No Relationships to Disclose
 
Mario Campone
Honoraria - Menarini; Novartis; Roche Pharma AG; SERVIER
Consulting or Advisory Role - Menarini; Novartis; Roche Pharma AG; SERVIER
Speakers' Bureau - Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis